Dr. Gur Jai Pal Singh is the Chief Scientific Advisor at BBSG Pharm Associates since June 2023. Before that he served as a Senior VP and headed a Pharma Company’s Respiratory Centre of Excellence – providing end-to-end hand-on leadership for state-of-the-art development of inhalation drug products. Under his leadership, several orally inhaled products have been successfully developed for the US, EU, and other geographies. Before coming to leadership roles in the private industry, Dr Singh had a 15-years tenure at the US FDA with designation of Senior Expert for Orally Inhaled and Nasal Drug Products (OINDP) – making key contributing to the Agency development of guidelines for OINDP. He has participated by invitation in a number of expert panels debating regulatory and product development issues related to respiratory drug products, and given invited lectures at lead international forums including, but not limited to, Respiratory Drug Delivery Conferences in the US and EU, International Society for Aerosols in Medicine, Pulmonary Drug Delivery Conference, Product Quality Research Institute (FDA-Academia-Industry), and IPAC-RS conferences. Dr Singh continues to play an active role in addressing scientific and regulatory issues in the development of complex respiratory drug products, with the current encompassing to include inhaled biologics.